{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:13:47Z","timestamp":1792098827952,"version":"4.4.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s10787-024-01592-y","type":"journal-article","created":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T12:24:19Z","timestamp":1732364659000},"page":"825-832","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Inhibition of alternative complement system and prolyl hydroxylase ameliorates anaemia of inflammation"],"prefix":"10.1007","volume":"33","author":[{"given":"Vishal J.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0723-4371","authenticated-orcid":false,"given":"Amit A.","family":"Joharapurkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samadhan G.","family":"Kshirsagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maulik S.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hardikkumar H.","family":"Savsani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan H.","family":"Rakhasiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshad S.","family":"Dodiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukul R.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,23]]},"reference":[{"key":"1592_CR1","doi-asserted-by":"publisher","first-page":"635670","DOI":"10.1155\/2015\/635670","volume":"2015","author":"W Barcellini","year":"2015","unstructured":"Barcellini W, Fattizzo B (2015) Clinical applications of hemolytic markers in the differential diagnosis and management of hemolytic anemia. Dis Markers 2015:635670. https:\/\/doi.org\/10.1155\/2015\/635670","journal-title":"Dis Markers"},{"key":"1592_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rce.2024.06.013","author":"S Conde D\u00edez","year":"2024","unstructured":"Conde D\u00edez S, de las Cuevas AR, Conde Garc\u00eda E (2024) Anemia of inflammation and iron metabolism in chronic diseases. Rev Clin Esp. https:\/\/doi.org\/10.1016\/j.rce.2024.06.013","journal-title":"Rev Clin Esp"},{"key":"1592_CR3","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"NP du Sert","year":"2020","unstructured":"du Sert NP, Hurst V, Ahluwalia A et al (2020) The arrive guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol 18:e3000410. https:\/\/doi.org\/10.1371\/journal.pbio.3000410","journal-title":"PLoS Biol"},{"key":"1592_CR4","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1073\/pnas.0910497107","volume":"107","author":"EN Gondwe","year":"2010","unstructured":"Gondwe EN, Molyneux ME, Goodall M et al (2010) Importance of antibody and complement for oxidative burst and killing of invasive nontyphoidal Salmonella by blood cells in Africans. Proc Natl Acad Sci USA 107:3070\u20133075. https:\/\/doi.org\/10.1073\/pnas.0910497107","journal-title":"Proc Natl Acad Sci USA"},{"key":"1592_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/J.EJPHAR.2018.11.023","volume":"843","author":"M Jain","year":"2019","unstructured":"Jain M, Joharapurkar A, Patel V et al (2019) Pharmacological inhibition of prolyl hydroxylase protects against inflammation-induced anemia via efficient erythropoiesis and hepcidin downregulation. Eur J Pharmacol 843:113\u2013120. https:\/\/doi.org\/10.1016\/J.EJPHAR.2018.11.023","journal-title":"Eur J Pharmacol"},{"key":"1592_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1055\/s-0035-1554630","volume":"66","author":"MR Jain","year":"2015","unstructured":"Jain MR, Joharapurkar AA, Pandya V et al (2015) Pharmacological characterization of ZYAN1, a novel prolyl hydroxylase inhibitor for the treatment of anemia. Drug Res 66:107\u2013112. https:\/\/doi.org\/10.1055\/s-0035-1554630","journal-title":"Drug Res"},{"key":"1592_CR7","doi-asserted-by":"crossref","unstructured":"Joharapurkar AA, Pandya VB, Patel VJ, et al (2018) Prolyl hydroxylase inhibitors: a breakthrough in the therapy of anemia associated with chronic diseases 61:6964\u20136982","DOI":"10.1021\/acs.jmedchem.7b01686"},{"key":"1592_CR8","doi-asserted-by":"publisher","first-page":"100102","DOI":"10.1016\/j.crphar.2022.100102","volume":"3","author":"AA Joharapurkar","year":"2022","unstructured":"Joharapurkar AA, Patel VJ, Kshirsagar SG et al (2022) Prolyl hydroxylase inhibitor desidustat improves anemia in erythropoietin hyporesponsive state. Curr Res Pharmacol Drug Discov 3:100102. https:\/\/doi.org\/10.1016\/j.crphar.2022.100102","journal-title":"Curr Res Pharmacol Drug Discov"},{"key":"1592_CR9","doi-asserted-by":"publisher","first-page":"e2104347118","DOI":"10.1073\/pnas.2104347118","volume":"118","author":"RS Keshari","year":"2021","unstructured":"Keshari RS, Popescu NI, Silasi R et al (2021) Complement C5 inhibition protects against hemolytic anemia and acute kidney injury in anthrax peptidoglycan-induced sepsis in baboons. Proc Natl Acad Sci USA 118:e2104347118. https:\/\/doi.org\/10.1073\/pnas.2104347118","journal-title":"Proc Natl Acad Sci USA"},{"key":"1592_CR10","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1097\/MIB.0000000000000417","volume":"21","author":"IE Koutroubakis","year":"2015","unstructured":"Koutroubakis IE, Ramos-Rivers C, Regueiro M et al (2015) The influence of anti-tumor necrosis factor agents on hemoglobin levels of patients with inflammatory bowel disease. Inflamm Bowel Dis 21:1587\u20131593. https:\/\/doi.org\/10.1097\/MIB.0000000000000417","journal-title":"Inflamm Bowel Dis"},{"key":"1592_CR11","doi-asserted-by":"publisher","first-page":"666","DOI":"10.3389\/fmicb.2015.00666","volume":"6","author":"K Orf","year":"2015","unstructured":"Orf K, Cunnington AJ (2015) Infection-related hemolysis and susceptibility to Gram-negative bacterial co-infection. Front Microbiol 6:666. https:\/\/doi.org\/10.3389\/fmicb.2015.00666","journal-title":"Front Microbiol"},{"key":"1592_CR12","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1182\/blood-2002-01-0136","volume":"100","author":"HA Papadaki","year":"2002","unstructured":"Papadaki HA, Kritikos HD, Valatas V et al (2002) Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-\u03b1 antibody therapy. Blood 100:474\u2013482. https:\/\/doi.org\/10.1182\/blood-2002-01-0136","journal-title":"Blood"},{"key":"1592_CR13","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1055\/A-1542-8531\/ID\/R2021-06-2300-0023","volume":"71","author":"V Patel","year":"2021","unstructured":"Patel V, Joharapurkar A, Kshirsagar S et al (2021) Hepcidin inhibition improves iron homeostasis in ferrous sulfate and LPS treatment model in mice. Drug Res 71:528\u2013534. https:\/\/doi.org\/10.1055\/A-1542-8531\/ID\/R2021-06-2300-0023","journal-title":"Drug Res"},{"key":"1592_CR14","doi-asserted-by":"publisher","first-page":"116832","DOI":"10.1016\/j.taap.2024.116832","volume":"483","author":"VJ Patel","year":"2024","unstructured":"Patel VJ, Joharapurkar A, Kshirsagar SG et al (2024a) HIF-PHD inhibitor desidustat ameliorates iron deficiency anemia. Toxicol Appl Pharmacol 483:116832. https:\/\/doi.org\/10.1016\/j.taap.2024.116832","journal-title":"Toxicol Appl Pharmacol"},{"key":"1592_CR15","doi-asserted-by":"publisher","first-page":"113029","DOI":"10.1016\/j.intimp.2024.113029","volume":"142","author":"VJ Patel","year":"2024","unstructured":"Patel VJ, Joharapurkar AA, Kshirsagar SG et al (2024b) Prolyl hydroxylase inhibitor desidustat attenuates autoimmune hemolytic anemia in mice. Int Immunopharmacol 142:113029. https:\/\/doi.org\/10.1016\/j.intimp.2024.113029","journal-title":"Int Immunopharmacol"},{"key":"1592_CR16","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1055\/a-2347-9919","volume":"74","author":"VJ Patel","year":"2024","unstructured":"Patel VJ, Joharapurkar AA, Kshirsagar SG et al (2024c) HIF stabilizer desidustat protects against complement-mediated diseases. Drug Res 74:325\u2013334. https:\/\/doi.org\/10.1055\/a-2347-9919","journal-title":"Drug Res"},{"key":"1592_CR17","doi-asserted-by":"publisher","first-page":"1418061","DOI":"10.3389\/fimmu.2024.1418061","volume":"15","author":"J Sun","year":"2024","unstructured":"Sun J, Chen C, Pan P et al (2024) The potential of bacterial anti-phagocytic proteins in suppressing the clearance of extracellular vesicles mediated by host phagocytosis. Front Immunol 15:1418061. https:\/\/doi.org\/10.3389\/fimmu.2024.1418061","journal-title":"Front Immunol"},{"key":"1592_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1182\/blood-2018-06-856500","volume":"133","author":"G Weiss","year":"2019","unstructured":"Weiss G, Ganz T, Goodnough LT (2019) Anemia of inflammation. Blood 133:40\u201350. https:\/\/doi.org\/10.1182\/blood-2018-06-856500","journal-title":"Blood"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01592-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-024-01592-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01592-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:05:30Z","timestamp":1740107130000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-024-01592-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,23]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1592"],"URL":"https:\/\/doi.org\/10.1007\/s10787-024-01592-y","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,23]]},"assertion":[{"value":"30 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors are employees of Zydus Research Centre, Zydus Lifesciences Limited. No author of this manuscript has any potential competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}